Ethics Drugs (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -97.78%
- Profit Growth 36.76%
- Ebitda 36.76%
- Net Worth -9.95%
- Total Assets -4.02%
About Ethics Drugs (India)
Ethics Drugs (India) Private Limited (EDIPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 February 2020 (Four years and 11 months 27 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vipin Patel and Sarita Patel serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239RJ2020PTC068391
- Company No.
068391
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Ethics Drugs (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipin Patel  | Director | 26-Feb-2020 | Current |
| Sarita Patel | Additional Director | 16-Aug-2021 | Current |
Financial Performance of Ethics Drugs (India).
Ethics Drugs (India) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 97.78% decrease. The company also saw a substantial improvement in profitability, with a 36.76% increase in profit. The company's net worth dipped by a decrease of 9.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ethics Drugs (India)?
In 2022, Ethics Drugs (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ethics Drugs (India)?
Unlock and access historical data on people associated with Ethics Drugs (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ethics Drugs (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ethics Drugs (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
